Application 206614

Type
ANDA
Sponsor
AUROBINDO PHARMA LTD

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RITONAVIRRITONAVIRTABLET;ORAL100MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
60687-420RitonavirRitonavirAmerican Health PackagingANDACurrent
60687-420RitonavirRitonavirAmerican Health PackagingANDACurrent
60687-420RitonavirRitonavirAmerican Health PackagingANDACurrent
60687-420RitonavirRitonavirAmerican Health PackagingANDACurrent
65862-687RitonavirRitonavirAurobindo Pharma LimitedANDACurrent
65862-687RitonavirRitonavirAurobindo Pharma LimitedANDACurrent
65862-687RitonavirRitonavirAurobindo Pharma LimitedANDACurrent
65862-687RitonavirRitonavirAurobindo Pharma LimitedANDACurrent
65862-687RitonavirRitonavirAurobindo Pharma LimitedANDACurrent
70518-2007RitonavirRitonavirREMEDYREPACK INC.ANDACurrent
70518-2007RitonavirRitonavirREMEDYREPACK INC.ANDACurrent